Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
Platform One Tackles Next Phase in Software Delivery
The software delivery engine sets its sights on DevSecOps infrastructure and preparing for a post-quantum future as it matures.
7m read -
Bird Flu Highlights Modernization Opportunities in Public Health Data
Experts are expanding data sharing and leveraging GIS technology to improve bird flu tracking, prediction and response.
5m read -
AI Summit
Join top IT officials to explore AI's latest advancements, challenges and future in the evolving tech landscape and discover how AI-powered solutions are revolutionizing efficiency and shaping the future of public and private sector operations.
Tysons, VA -
Federal IT Efficiency Summit
The CyberScape Summit will bring together federal and industry thought leaders to explore key priorities in cybersecurity and stay ahead of evolving challenges.
To Be Announced
